Health & Pharm General

Regeneus Ltd (ASX:RGS) Potential Japan Licence Deal a STEP Closer

🕔5/20/2016 11:18:35 AM

Regeneus Ltd (ASX:RGS) announce that an investment report by Edison titled "Potential Japan licence deal a STEP closer" has been published on the Regeneus website.

Read Full Article

Regeneus Ltd (ASX:RGS) Australian Research Council Linkage Grant to Progress Stem Cell Research into Treating Chronic Pain

🕔5/17/2016 9:14:11 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced the Australian Research Council (ARC) had awarded a Linkage Grant of $340,000 to a research consortium that includes Regeneus collaborating with leading researchers from Macquarie University and the University of Adelaide.

Read Full Article

Regeneus Ltd (ASX:RGS) Enrolment Complete and Positive Safety in Progenza Trial For Osteoarthritis

🕔5/16/2016 9:23:45 AM

Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced completion of enrolment of all 20 patients in the STEP trial. Further, a review of the cumulative study safety data by the study safety oversight committee identified no safety concerns.

Read Full Article

The Life Sciences Report: Advantage: Australia. Biotechs Surge Ahead in Regenerative Medicine and Immuno-Oncology

🕔5/15/2016 10:23:22 AM

The Life Sciences Report: Advantage: Australia. Biotechs Surge Ahead in Regenerative Medicine and Immuno-Oncology

Read Full Article

Traditional Therapy Clinics Ltd (ASX:TTC) Acquires Further 3 Clinics

🕔5/13/2016 9:12:44 AM

Traditional Therapy Clinics Limited (ASX:TTC) through its wholly owned subsidiary, Fuqiao (Chongqing) Holdings Co. Limited, has entered into contracts to acquire a further three (3) clinics from its franchised clinic base in line with its business strategy.

Read Full Article

Blackmores Limited (ASX:BKL) Shareholder Briefing

🕔5/6/2016 10:18:55 AM

Blackmores Limited (ASX:BKL) Shareholder Briefing including Blackmores' Asia Market Strategy.

Read Full Article

FINANCE VIDEO: Blackmores Ltd (ASX:BKL) CEO Christine Holgate and Paul Keogh Share Insights into the New Acquisition

🕔5/6/2016 8:18:43 AM

Following a strong year to date performance delivering sales and profit growth from all areas of the business, Blackmores Ltd (ASX:BKL) has announced their acquisition of Global Therapeutics, Australia's leading Chinese herbal medicine company.

Read Full Article